Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study

por Shi, Nianmin, Rasuli, Anvar, Thollot, Yaël
Publicado 2018

Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim(®) 160U) in South Korea from 2011 to 2015

por Kim, HeeSoo, Oh, Yongho, Thollot, Yael, Bravo, Catherine
Publicado 2019

Post-Marketing Surveillance Observational Study of Quadrivalent Meningococcal Diphtheria Toxoid Conjugate Vaccine (MenACWY-DT, MCV4/Menactra(®)) in the Republic of Korea, 2014–2019...

por Kim, Hee Soo, Engel, Solene, Neveu, David, Thollot, Yael, Oster, Philipp, Yang, Kuhyun
Publicado 2021

Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina

por Espul, Carlos, Benedetti, Laura, Linares, Mariela, Cuello, Hector, Lo Castro, Ivana, Thollot, Yaël, Rasuli, Anvar
Publicado 2017

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C...

por Knuf, Markus, Rämet, Mika, Breinholt Stærke, Nina, Bertrand-Gerentes, Isabelle, Thollot, Yaël, B'Chir, Siham, Arroum, Habiba, Oster, Philipp
Publicado 2022

Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial

por Cordero De Los Santos, Lina, Feris-Iglesias, Jesús, Aloysia D'Cor, Naveena, Midde, Venkata Jayanth, Patnaik, Badri Narayan, Thollot, Yaël, Rasuli, Anvar, Desauziers, Eric
Publicado 2018

Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines

por Capeding, Maria Rosario Z., Gonzales, Maria Liza Antoinette M., Dhingra, Mandeep Singh, D'Cor, Naveena Aloysia, Midde, Venkat Jayanth, Patnaik, Badri Narayan, Thollot, Yaël, Desauziers, Eric
Publicado 2017